SBH 10-Q Quarterly Report June 30, 2024 | Alphaminr
Sally Beauty Holdings, Inc.

SBH 10-Q Quarter ended June 30, 2024

SALLY BEAUTY HOLDINGS, INC.
10-Ks and 10-Qs
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
10-Q
2024 0001368458 Q3 --09-30 false P3Y April 30, 2026 0001368458 2023-03-31 0001368458 us-gaap:CommonStockMember 2022-12-31 0001368458 sbh:SallyHoldingsMember us-gaap:InterestRateCapMember sbh:VariableRateTrancheMember 2023-10-01 2024-06-30 0001368458 us-gaap:FranchisedUnitsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2022-10-01 2023-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesChannelDirectlyToConsumerMember sbh:BeautySystemsGroupMember us-gaap:EntityOperatedUnitsMember 2023-10-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2022-10-01 2023-06-30 0001368458 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2023-04-01 2023-06-30 0001368458 us-gaap:BaseRateMember sbh:SallyHoldingsMember sbh:TLBTwentyThirtyMember 2024-06-14 2024-06-14 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember sbh:HairCareMember 2022-10-01 2023-06-30 0001368458 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember 2022-10-01 2023-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2023-04-01 2023-06-30 0001368458 us-gaap:CorporateNonSegmentMember 2024-04-01 2024-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2023-10-01 2024-06-30 0001368458 2023-10-01 2023-12-31 0001368458 us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember sbh:BeautySystemsGroupMember 2022-10-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember sbh:HairCareMember 2023-10-01 2024-06-30 0001368458 us-gaap:InterestRateSwapMember sbh:SallyHoldingsMember 2023-10-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember 2023-04-01 2023-06-30 0001368458 sbh:TermLoanBMember us-gaap:FairValueInputsLevel2Member 2024-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember sbh:HairColorMember 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:HairCareMember sbh:BeautySystemsGroupMember 2023-04-01 2023-06-30 0001368458 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2024-06-30 0001368458 us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember sbh:SallyHoldingsMember sbh:TLBTwentyThirtyMember 2024-06-14 2024-06-14 0001368458 us-gaap:DesignatedAsHedgingInstrumentMember currency:CAD 2024-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2022-10-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2024-04-01 2024-06-30 0001368458 us-gaap:OperatingSegmentsMember 2023-10-01 2024-06-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2024-06-30 0001368458 2023-04-01 2023-06-30 0001368458 us-gaap:CorporateNonSegmentMember 2023-04-01 2023-06-30 0001368458 sbh:BeautySystemsGroupMember 2024-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001368458 us-gaap:CommonStockMember 2024-03-31 0001368458 sbh:DistributorSalesConsultantsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2023-04-01 2023-06-30 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0001368458 us-gaap:RetainedEarningsMember 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:OtherBeautyItemsMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2024-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2023-10-01 2024-06-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2024-04-01 2024-06-30 0001368458 2022-10-01 2022-12-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2023-10-01 2024-06-30 0001368458 us-gaap:InterestRateSwapMember 2023-09-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember sbh:BeautySystemsGroupMember 2023-04-01 2023-06-30 0001368458 us-gaap:DesignatedAsHedgingInstrumentMember currency:EUR 2024-06-30 0001368458 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember 2023-10-01 2024-06-30 0001368458 us-gaap:RetainedEarningsMember 2022-09-30 0001368458 us-gaap:CorporateNonSegmentMember 2023-10-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesChannelDirectlyToConsumerMember sbh:BeautySystemsGroupMember us-gaap:EntityOperatedUnitsMember 2023-04-01 2023-06-30 0001368458 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2023-10-01 2024-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2024-06-30 0001368458 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:NailMember sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 sbh:SallyBeautySupplyMember 2023-10-01 2024-06-30 0001368458 us-gaap:OperatingSegmentsMember sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 sbh:SallyHoldingsMember us-gaap:InterestRateCapMember sbh:VariableRateTrancheMember 2017-07-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:HairCareMember sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 us-gaap:NondesignatedMember currency:MXN 2024-06-30 0001368458 us-gaap:CorporateNonSegmentMember 2022-10-01 2023-06-30 0001368458 2023-09-30 0001368458 us-gaap:InterestRateSwapMember sbh:SallyHoldingsMember 2023-04-01 2023-04-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember 2024-04-01 2024-06-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2022-10-01 2023-06-30 0001368458 us-gaap:OperatingSegmentsMember sbh:BeautySystemsGroupMember 2023-04-01 2023-06-30 0001368458 us-gaap:RetainedEarningsMember 2024-06-30 0001368458 us-gaap:CommonStockMember 2023-03-31 0001368458 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001368458 sbh:ShareRepurchaseProgram2017Member 2024-06-30 0001368458 2024-01-01 2024-03-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:OtherBeautyItemsMember sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:OtherBeautyItemsMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember 2023-10-01 2024-06-30 0001368458 us-gaap:OperatingSegmentsMember sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 2023-10-01 2024-06-30 0001368458 2023-06-30 0001368458 us-gaap:InterestRateSwapMember sbh:SallyHoldingsMember 2024-04-01 2024-06-30 0001368458 2022-09-30 0001368458 2024-03-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2017-08-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 sbh:BeautySystemsGroupMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:HairColorMember 2023-10-01 2024-06-30 0001368458 us-gaap:ForeignExchangeContractMember 2023-10-01 2024-06-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001368458 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:HairCareMember 2022-10-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:HairCareMember sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 us-gaap:NondesignatedMember currency:GBP 2024-06-30 0001368458 us-gaap:CommonStockMember 2023-06-30 0001368458 us-gaap:RetainedEarningsMember 2023-03-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember sbh:HairColorMember 2024-04-01 2024-06-30 0001368458 us-gaap:DesignatedAsHedgingInstrumentMember currency:MXN 2024-06-30 0001368458 us-gaap:FranchisedUnitsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2023-04-01 2023-06-30 0001368458 us-gaap:FranchisedUnitsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2024-04-01 2024-06-30 0001368458 us-gaap:FairValueInputsLevel2Member us-gaap:OtherAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001368458 us-gaap:SalesRevenueNetMember sbh:OtherBeautyItemsMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember 2022-10-01 2023-06-30 0001368458 sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 sbh:AssetBasedSeniorSecuredLoanFacilityMember 2024-06-30 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-04-01 2024-06-30 0001368458 sbh:SeniorNotesDueDecemberTwoThousandTwentyFiveMember 2024-03-13 2024-03-13 0001368458 us-gaap:SalesRevenueNetMember sbh:OtherBeautyItemsMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember sbh:HairColorMember 2022-10-01 2023-06-30 0001368458 us-gaap:RetainedEarningsMember 2023-09-30 0001368458 sbh:SallyBeautySupplyMember 2022-10-01 2023-06-30 0001368458 us-gaap:LineOfCreditMember 2024-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001368458 sbh:GoldwellMember 2023-10-01 2024-06-30 0001368458 sbh:DistributionCenterConsolidationAndStoreOptimizationPlanMember 2023-10-01 2024-06-30 0001368458 sbh:ShareRepurchaseProgram2017Member 2022-10-01 2023-06-30 0001368458 sbh:BeautySystemsGroupMember 2022-10-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:HairCareMember 2023-04-01 2023-06-30 0001368458 us-gaap:RetainedEarningsMember 2023-12-31 0001368458 sbh:SallyHoldingsMember sbh:TLBTwentyThirtyMember 2024-06-14 2024-06-14 0001368458 2023-01-01 2023-03-31 0001368458 us-gaap:SalesRevenueNetMember sbh:OtherBeautyItemsMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2022-10-01 2023-06-30 0001368458 us-gaap:FairValueInputsLevel2Member us-gaap:AccruedLiabilitiesMember us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember sbh:HairColorMember 2023-10-01 2024-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001368458 sbh:SeniorNotesDueTwoThousandThirtyTwoMember 2024-02-27 2024-02-27 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2024-06-30 0001368458 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001368458 sbh:DistributorSalesConsultantsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2023-10-01 2024-06-30 0001368458 sbh:DistributionCenterConsolidationAndStoreOptimizationPlanMember 2022-10-01 2023-06-30 0001368458 2022-12-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-10-01 2023-06-30 0001368458 us-gaap:FranchisedUnitsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2023-10-01 2024-06-30 0001368458 us-gaap:InterestRateSwapMember 2023-10-01 2024-06-30 0001368458 sbh:DistributorSalesConsultantsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2022-10-01 2023-06-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2023-04-01 2023-06-30 0001368458 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember sbh:NailMember 2024-04-01 2024-06-30 0001368458 us-gaap:OperatingSegmentsMember sbh:BeautySystemsGroupMember 2022-10-01 2023-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001368458 us-gaap:InterestRateSwapMember sbh:SallyHoldingsMember 2023-04-30 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2023-10-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2022-10-01 2023-06-30 0001368458 us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001368458 sbh:SeniorNotesDueDecemberTwoThousandTwentyFiveMember 2024-02-12 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001368458 sbh:SeniorNotesDueDecemberTwoThousandTwentyFiveMember 2024-02-12 2024-02-12 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:HairColorMember 2023-04-01 2023-06-30 0001368458 sbh:ShareRepurchaseProgram2017Member 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 us-gaap:OperatingSegmentsMember 2023-04-01 2023-06-30 0001368458 us-gaap:CommonStockMember 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2023-04-01 2023-06-30 0001368458 us-gaap:CommonStockMember 2022-09-30 0001368458 2024-04-01 2024-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001368458 sbh:SeniorNotesDueTwoThousandThirtyTwoMember 2023-10-01 2024-06-30 0001368458 2024-08-02 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesChannelDirectlyToConsumerMember sbh:BeautySystemsGroupMember us-gaap:EntityOperatedUnitsMember 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:HairCareMember 2024-04-01 2024-06-30 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2023-09-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001368458 us-gaap:ValuationTechniqueDiscountedCashFlowMember sbh:BeautySystemsGroupMember 2023-09-30 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001368458 us-gaap:RetainedEarningsMember 2024-03-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesChannelDirectlyToConsumerMember sbh:BeautySystemsGroupMember us-gaap:EntityOperatedUnitsMember 2022-10-01 2023-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001368458 sbh:SeniorNotesDueDecemberTwoThousandTwentyFiveMember 2024-02-27 0001368458 us-gaap:FairValueInputsLevel2Member us-gaap:OtherAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001368458 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel1Member 2024-06-30 0001368458 us-gaap:InterestRateSwapMember 2024-06-30 0001368458 currency:CAD us-gaap:NondesignatedMember 2024-06-30 0001368458 us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:MeasurementInputDiscountRateMember sbh:BeautySystemsGroupMember 2023-09-30 0001368458 sbh:SeniorNotesDueDecemberTwoThousandTwentyFiveMember 2024-02-27 2024-02-27 0001368458 sbh:SallyBeautySupplyMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 sbh:SeniorNotesDueTwoThousandThirtyTwoMember 2024-02-27 0001368458 us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:NailMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-06-30 0001368458 sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 sbh:SallyBeautySupplyMember 2024-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember 2023-10-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2023-10-01 2024-06-30 0001368458 currency:EUR us-gaap:NondesignatedMember 2024-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2022-10-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember 2023-04-01 2023-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001368458 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:NailMember 2023-10-01 2024-06-30 0001368458 sbh:TermLoanBMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember sbh:HairColorMember 2023-04-01 2023-06-30 0001368458 sbh:DistributorSalesConsultantsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember 2024-04-01 2024-06-30 0001368458 sbh:SallyBeautySupplyMember 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2024-04-01 2024-06-30 0001368458 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001368458 sbh:DistributionCenterConsolidationAndStoreOptimizationPlanMember 2023-04-01 2023-06-30 0001368458 us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001368458 us-gaap:ValuationTechniqueDiscountedCashFlowMember sbh:BeautySystemsGroupMember us-gaap:MeasurementInputLongTermRevenueGrowthRateMember 2023-09-30 0001368458 us-gaap:SalesRevenueNetMember sbh:OtherBeautyItemsMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2023-04-01 2023-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001368458 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 sbh:ShareRepurchaseProgram2017Member 2023-04-01 2023-06-30 0001368458 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueInputsLevel2Member us-gaap:AccruedLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:OtherBeautyItemsMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2023-10-01 2024-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001368458 us-gaap:InterestRateSwapMember sbh:SallyHoldingsMember 2024-06-30 0001368458 sbh:ShareRepurchaseProgram2017Member 2021-07-01 2021-07-31 0001368458 us-gaap:OperatingSegmentsMember 2022-10-01 2023-06-30 0001368458 us-gaap:InterestRateSwapMember sbh:SallyHoldingsMember 2022-10-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember sbh:NailMember 2023-04-01 2023-06-30 0001368458 us-gaap:InterestRateSwapMember sbh:SallyHoldingsMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SkinAndCosmeticsMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember 2024-04-01 2024-06-30 0001368458 2022-10-01 2023-06-30 0001368458 us-gaap:FairValueInputsLevel2Member us-gaap:AccruedLiabilitiesMember us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember 2023-04-01 2023-06-30 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2023-10-01 2024-06-30 0001368458 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:NailMember sbh:BeautySystemsGroupMember 2024-04-01 2024-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:SallyBeautySupplyMember sbh:HairColorMember 2022-10-01 2023-06-30 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-10-01 2024-06-30 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2024-06-30 0001368458 us-gaap:CommonStockMember 2023-09-30 0001368458 us-gaap:CommonStockMember 2023-12-31 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:StylingToolsAndSuppliesMember 2022-10-01 2023-06-30 0001368458 sbh:ShareRepurchaseProgram2017Member 2023-10-01 2024-06-30 0001368458 sbh:SeniorNotesDueTwoThousandThirtyTwoMember 2024-02-12 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember sbh:NailMember 2022-10-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember sbh:SallyBeautySupplyMember us-gaap:ProductConcentrationRiskMember sbh:NailMember 2022-10-01 2023-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001368458 us-gaap:RetainedEarningsMember 2022-12-31 0001368458 2023-12-31 0001368458 sbh:DistributionCenterConsolidationAndStoreOptimizationPlanMember 2024-04-01 2024-06-30 0001368458 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001368458 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember sbh:BeautySystemsGroupMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember 2022-10-01 2023-06-30 0001368458 2024-06-30 xbrli:pure sbh:Derivative xbrli:shares sbh:Instrument iso4217:USD xbrli:shares iso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2024

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 1-33145

SALLY BEAUTY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

36-2257936

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

3001 Colorado Boulevard

Denton , Texas

76210

(Address of principal executive offices)

(Zip Code)

( 800 ) 777-5706

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, $0.01 par value

SBH

The New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

Number of shares of common stock outstanding as of August 2, 2024: 102,642,597


TABLE OF CONTENTS

Page

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

4

Condensed Consolidated Balance Sheets

4

Condensed Consolidated Statements of Earnings

5

Condensed Consolidated Statements of Comprehensive Income

6

Condensed Consolidated Statements of Stockholders’ Equity

7

Condensed Consolidated Statements of Cash Flows

8

Notes to Condensed Consolidated Financial Statements

9

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

Item 3. Quantitative and Qualitative Disclosures About Market Risk

24

Item 4. Controls and Procedures

24

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

25

Item 1A. Risk Factors

25

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.

25

Item 5. Other Information

25

Item 6. Exhibits

26

2


In this Quarterly Report, references to “the Company,” “Sally Beauty,” “our company,” “we,” “our,” “ours” and “us” refer to Sally Beauty Holdings, Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q and in the documents incorporated by reference herein which are not purely historical facts or which depend upon future events may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, "the Exchange Act." Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “would” or similar expressions may also identify such forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, which should be read in conjunction with the forward-looking statements in this report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

3


PART I — FINANCI AL INFORMATION

Item 1. Financi al Statements.

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Ba lance Sheets

(In thousands, except par value data)

June 30,
2024

September 30,
2023

(Unaudited)

Assets

Current assets:

Cash and cash equivalents

$

97,375

$

123,001

Trade accounts receivable, net

32,766

33,421

Accounts receivable, other

58,647

42,454

Inventory

1,022,380

975,218

Other current assets

51,396

53,903

Total current assets

1,262,564

1,227,997

Property and equipment, net of accumulated depreciation of $ 855,058 at
June 30, 2024, and $
780,212 at September 30, 2023

267,829

297,779

Operating lease assets

560,602

570,657

Goodwill

533,951

533,081

Intangible assets, excluding goodwill, net of accumulated amortization of
$
32,435 at June 30, 2024, and $ 30,587 at September 30, 2023

53,275

55,171

Other assets

42,976

40,565

Total assets

$

2,721,197

$

2,725,250

Liabilities and Stockholders’ Equity

Current liabilities:

Current maturities of long-term debt

$

49,163

$

4,173

Accounts payable

234,552

258,884

Accrued liabilities

161,191

163,366

Current operating lease liabilities

136,524

150,479

Income taxes payable

13,495

2,355

Total current liabilities

594,925

579,257

Long-term debt

978,865

1,065,811

Long-term operating lease liabilities

457,169

455,071

Other liabilities

21,375

23,139

Deferred income tax liabilities, net

91,193

93,224

Total liabilities

2,143,527

2,216,502

Stockholders’ equity:

Common stock, $ 0.01 par value. Authorized 500,000 shares; 102,643 and
106,266 shares issued and shares outstanding at June 30, 2024, and
September 30, 2023, respectively

1,026

1,063

Preferred stock, $ 0.01 par value. Authorized 50,000 shares; no ne issued

Additional paid-in capital

5,677

Accumulated earnings

698,498

624,772

Accumulated other comprehensive loss, net of tax

( 121,854

)

( 122,764

)

Total stockholders’ equity

577,670

508,748

Total liabilities and stockholders’ equity

$

2,721,197

$

2,725,250

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Stateme nts of Earnings

(In thousands, except per share data)

(Unaudited)

Three Months Ended

Nine Months Ended

June 30,

June 30,

2024

2023

2024

2023

Net sales

$

942,340

$

931,008

$

2,782,003

$

2,806,775

Cost of goods sold

461,457

456,303

1,370,872

1,375,157

Gross profit

480,883

474,705

1,411,131

1,431,618

Selling, general and administrative expenses

408,730

384,183

1,210,303

1,165,420

Restructuring

383

397

361

18,077

Operating earnings

71,770

90,125

200,467

248,121

Interest expense

20,707

18,654

58,544

53,262

Earnings before provision for income taxes

51,063

71,471

141,923

194,859

Provision for income taxes

13,339

20,650

36,565

52,840

Net earnings

$

37,724

$

50,821

$

105,358

$

142,019

Earnings per share:

Basic

$

0.37

$

0.47

$

1.01

$

1.32

Diluted

$

0.36

$

0.46

$

0.98

$

1.30

Weighted-average shares:

Basic

103,190

107,560

104,477

107,383

Diluted

105,897

109,668

107,186

109,519

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehe nsive Income

(In thousands)

(Unaudited)

Three Months Ended

Nine Months Ended

June 30,

June 30,

2024

2023

2024

2023

Net earnings

$

37,724

$

50,821

$

105,358

$

142,019

Other comprehensive income (loss):

Foreign currency translation adjustments

( 5,955

)

4,576

1,494

39,962

Interest rate swap, net of tax

46

2,806

( 1,458

)

2,806

Interest rate caps, net of tax

( 1,960

)

Foreign exchange contracts, net of tax

887

( 10

)

874

( 1,937

)

Other comprehensive income (loss), net of tax

( 5,022

)

7,372

910

38,871

Total comprehensive income

$

32,702

$

58,193

$

106,268

$

180,890

The accompanying notes are an integral part of these condensed consolidated financial statements.

6


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockh olders’ Equity

(In thousands)

(Unaudited)

Accumulated

Additional

Other

Total

Common Stock

Paid-in

Accumulated

Comprehensive

Stockholders’

Shares

Amount

Capital

Earnings

Loss

Equity

Balance at September 30, 2023

106,266

$

1,063

$

5,677

$

624,772

$

( 122,764

)

$

508,748

Net earnings

38,390

38,390

Other comprehensive income

10,808

10,808

Share-based compensation

5,118

5,118

Stock issued for equity awards

722

7

209

216

Employee withholding taxes paid
related to net share settlement

( 192

)

( 2

)

( 1,738

)

( 1,740

)

Repurchases and cancellations of
common stock

( 1,939

)

( 19

)

( 9,266

)

( 10,915

)

( 20,200

)

Balance at December 31, 2023

104,857

$

1,049

$

$

652,247

$

( 111,956

)

$

541,340

Net earnings

29,244

29,244

Other comprehensive loss

( 4,876

)

( 4,876

)

Share-based compensation

3,964

3,964

Stock issued for equity awards

184

2

1,396

1,398

Employee withholding taxes paid
related to net share settlement

( 1

)

( 1

)

( 19

)

( 20

)

Repurchases and cancellations of
common stock

( 1,526

)

( 15

)

( 5,341

)

( 14,844

)

( 20,200

)

Balance at March 31, 2024

103,514

$

1,035

$

$

666,647

$

( 116,832

)

$

550,850

Net earnings

37,724

37,724

Other comprehensive loss

( 5,022

)

( 5,022

)

Share-based compensation

4,178

4,178

Stock issued for equity awards

5

40

40

Repurchases and cancellations of
common stock

( 876

)

( 9

)

( 4,218

)

( 5,873

)

( 10,100

)

Balance at June 30, 2024

102,643

$

1,026

$

$

698,498

$

( 121,854

)

$

577,670

Accumulated

Additional

Other

Total

Common Stock

Paid-in

Accumulated

Comprehensive

Stockholders’

Shares

Amount

Capital

Earnings

Loss

Equity

Balance at September 30, 2022

106,970

$

1,070

$

4,241

$

440,172

$

( 151,847

)

$

293,636

Net earnings

50,337

50,337

Other comprehensive income

25,234

25,234

Share-based compensation

5,135

5,135

Stock issued for equity awards

404

4

78

82

Employee withholding taxes paid
related to net share settlement

( 90

)

( 1

)

( 1,125

)

( 1,126

)

Balance at December 31, 2022

107,284

$

1,073

$

8,329

$

490,509

$

( 126,613

)

$

373,298

Net earnings

40,861

40,861

Other comprehensive income

6,265

6,265

Share-based compensation

3,838

3,838

Stock issued for equity awards

266

3

1,638

1,641

Employee withholding taxes paid
related to net share settlement

( 1

)

( 15

)

( 15

)

Balance at March 31, 2023

107,549

$

1,076

$

13,790

$

531,370

$

( 120,348

)

$

425,888

Net earnings

50,821

50,821

Other comprehensive income

7,372

7,372

Share-based compensation

3,550

3,550

Stock issued for equity awards

15

81

81

Balance at June 30, 2023

107,564

$

1,076

$

17,421

$

582,191

$

( 112,976

)

$

487,712

The accompanying notes are an integral part of these condensed consolidated financial statements.

7


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of C ash Flows

(In thousands)

(Unaudited)

Nine Months Ended June 30,

2024

2023

Cash Flows from Operating Activities:

Net earnings

$

105,358

$

142,019

Adjustments to reconcile net earnings to net cash provided
by operating activities:

Depreciation and amortization

83,533

75,773

Share-based compensation expense

13,260

12,523

Amortization of deferred financing costs

1,872

1,998

Loss on early extinguishment of debt

3,734

601

Impairment of long-lived assets, including operating lease assets

626

2,070

Loss on disposal of equipment and other property

4

3

Deferred income taxes

( 6,509

)

( 1,168

)

Changes in (exclusive of effects of acquisitions):

Trade accounts receivable

815

2,364

Accounts receivable, other

( 15,954

)

( 5,307

)

Inventory

( 46,716

)

( 37,310

)

Other current assets

2,914

3,323

Other assets

( 445

)

286

Operating leases, net

( 2,421

)

( 14,762

)

Accounts payable and accrued liabilities

( 13,615

)

( 51,581

)

Income taxes payable

11,158

1,959

Other liabilities

( 1,759

)

( 20

)

Net cash provided by operating activities

135,855

132,771

Cash Flows from Investing Activities:

Payments for property and equipment, net of proceeds

( 63,808

)

( 63,796

)

Acquisitions, net of cash acquired

( 218

)

Net cash used by investing activities

( 64,026

)

( 63,796

)

Cash Flows from Financing Activities:

Proceeds from issuance of long-term debt and ABL facility

1,345,458

1,069,000

Repayments of long-term debt and ABL facility

( 1,383,553

)

( 1,133,134

)

Debt issuance costs

( 9,135

)

( 4,788

)

Proceeds from equity awards

1,654

1,804

Payments for common stock repurchased

( 50,500

)

Employee withholding taxes paid related to net share settlement of equity awards

( 1,759

)

( 1,141

)

Net cash used by financing activities

( 97,835

)

( 68,259

)

Effect of foreign exchange rate changes on cash and cash equivalents

380

3,063

Net increase (decrease) in cash and cash equivalents

( 25,626

)

3,779

Cash and cash equivalents, beginning of period

123,001

70,558

Cash and cash equivalents, end of period

$

97,375

$

74,337

Supplemental Cash Flow Information:

Interest paid

$

56,498

$

63,455

Income taxes paid

$

34,477

$

52,123

Capital expenditures incurred but not paid

$

9,970

$

6,319

The accompanying notes are an integral part of these condensed consolidated financial statements.

8


Sally Beauty Holdings, Inc. and Subsidiaries

Notes to Condensed Cons olidated Financial Statements

(Unaudited)

1. Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly our consolidated financial position as of June 30, 2024, and September 30, 2023, our consolidated results of operations, consolidated comprehensive income and consolidated statements of stockholders’ equity for the three and nine months ended June 30, 2024 and 2023, and consolidated cash flows for the nine months ended June 30, 2024 and 2023 .

Principles of Consolidation

The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. All amounts are in U.S. Dollars.

Accounting Policies

We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

Use of Estimates

In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however they are subject to change in the future. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.

2. Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , to enhance segment disclosures for annual and interim consolidated financial statements, including significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”). For public companies, the amendments in the update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but we do not expect the update to impact our consolidated results of operations or financial position.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , to expand disclosures in an entity’s income tax rate reconciliation table and the disaggregation of taxes paid in U.S. and foreign jurisdictions. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but we do not expect the update to impact our consolidated results of operations or financial position.

9


3. Revenue Recognition

Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale. Revenue is recognized net of estimated sales returns and sales taxes. We estimate sales returns based on historical data.

Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, for the periods were as follows (in thousands):

Nine Months Ended June 30,

2024

2023

Beginning Balance

$

14,038

$

13,460

Loyalty points and gift cards issued but not redeemed, net of estimated breakage

9,266

12,438

Revenue recognized from beginning liability

( 11,252

)

( 11,669

)

Ending Balance

$

12,052

$

14,229

See Note 11, Segment Reporting , for additional information regarding the disaggregation of our sales revenue.

4. Fair Value Measurements

We measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC Topic 820, Fair Value Measurement, as amended (“ASC 820”). We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date.

The three levels of that hierarchy are defined as follows:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities;

Level 2 - Pricing inputs are other than quoted prices in active markets, included in Level 1, that are either directly or indirectly observable; and

Level 3 - Unobservable pricing inputs in which little or no market activity exists, therefore requiring an entity to develop its own model with estimates and assumptions.

Financial instruments measured at fair value on recurring basis

Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follows:

(in thousands)

Classification

Fair Value Hierarchy Level

June 30,
2024

September 30,
2023

Financial Assets:

Foreign exchange contracts

Non-designated cash flow hedges

Other current assets

Level 2

$

1,028

$

1,160

Interest rate swap

Other assets

Level 2

2,982

4,668

Total assets

$

4,010

$

5,828

.

Financial Liabilities:

Foreign exchange contracts

Designated cash flow hedges

Accrued liabilities

Level 2

$

146

$

Non-designated cash flow hedges

Accrued liabilities

Level 2

197

397

Total liabilities

$

343

$

397

The fair value of each asset and liability were measured using widely accepted valuation techniques, including discounted cash flow analyses and observable inputs, such as market interest rates and foreign exchange rates.

10


Other fair value disclosures

The carrying amounts of cash equivalents, trade and other accounts receivable, and accounts payable and borrowing under our $ 500 million asset-based senior secured loan facility (the “ABL facility”) approximate their respective fair values due to the short-term nature of these financial instruments. Carrying amounts and the related estimated fair value of our long-term debt, excluding finance lease obligations, debt issuance costs and original issue discounts, are as follows:

June 30, 2024

September 30, 2023

(in thousands)

Fair Value Hierarchy Level

Carrying Value

Fair Value

Carrying Value

Fair Value

Long-term debt, excluding finance lease obligations

Senior notes

Level 1

$

600,000

$

592,500

$

679,961

$

662,962

Term loan B

Level 2

395,000

394,013

398,000

398,000

Total long-term debt

$

995,000

$

986,513

$

1,077,961

$

1,060,962

The fair values of our term loans were measured using quoted market prices for similar debt securities in active markets or widely accepted valuation techniques, such as discounted cash flow analyses, using observable inputs, such as market interest rates.

5. Stockholders’ Equity

Share Repurchases

In August 2017, our Board of Directors (“Board”) approved a share repurchase program authorizing us to repurchase up to $ 1.0 billion of our common stock, subject to certain limitations governed by our debt agreements. In July 2021, our Board approved a term extension of our share repurchase program to September 30, 2025 . As of June 30, 2024, we had approximately $ 530.8 million of additional share repurchase authorizations remaining under our share repurchase program. For the three and nine months ended June 30, 2024 , we repurchased 0.9 million and 4.3 million shares of our common stock at a total cost of $ 10.0 million and $ 50.0 million, respectively, excluding the impact of excise taxes. For the three and nine months ended June 30, 2023 , we did no t repurchase shares under our share repurchase program.

Accumulated Other Comprehensive Loss

The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

Foreign Currency Translation Adjustments

Interest Rate Swap

Foreign Exchange Contracts

Total

Balance at September 30, 2023

$

( 124,846

)

$

3,716

$

( 1,634

)

$

( 122,764

)

Other comprehensive income (loss) before
reclassification, net of tax

1,494

382

( 1,043

)

833

Reclassification to net earnings, net of tax

( 1,840

)

1,917

77

Balance at June 30, 2024

$

( 123,352

)

$

2,258

$

( 760

)

$

( 121,854

)

The tax impact for the changes in other comprehensive income (loss) and the reclassifications to net earnings was not material.

6. Weighted-Average Shares

The following table sets forth the reconciliation of basic and diluted weighted-average shares (in thousands):

Three Months Ended
June 30,

Nine Months Ended
June 30,

2024

2023

2024

2023

Weighted-average basic shares

103,190

107,560

104,477

107,383

Dilutive securities:

Stock option and stock award programs

2,707

2,108

2,709

2,136

Weighted-average diluted shares

105,897

109,668

107,186

109,519

Anti-dilutive options excluded from our computation of diluted shares

1,678

1,896

1,678

1,896

11


7. Goodwill and Intangible Assets

During the three months ended March 31, 2024, we completed our annual assessments for impairment of goodwill and indefinite-lived intangible assets. For our goodwill testing, we performed a qualitative analysis and determined that there was no indication of impairment requiring further quantitative testing. No material impairment losses were recognized in the current or prior periods presented in connection with our goodwill and intangible assets.

At September 30, 2023, we determined that due to the recent decline in the Company’s share price and market capitalization, among other factors, a quantitative assessment was required. Based on our September 30, 2023, quantitative assessment using a discounted cash flow, we estimated the fair value for our Beauty Systems Group (“BSG”) reporting unit to be approximately 18 % more than its carrying value. T he critical assumptions used as part of our evaluation included a projected long-term revenue growth rate of 2.0 % and a discount rate of 11.25 %, based on a weighted-average cost of capital analysis (adjusted for company-specific risk). Our September 30, 2023, quantitative assessment indicated that the fair value of our SBS segment was substantially higher than its carrying value. Goodwill allocated to our SBS and BSG reporting units, which are also defined as our SBS and BSG segment, was $ 84.8 million and $ 449.2 million, respectively, as of June 30, 2024.

Three Months Ended
June 30,

Nine Months Ended
June 30,

(in thousands)

2024

2023

2024

2023

Intangible assets amortization expense

$

764

$

807

$

2,415

$

2,682

For the nine months ended June 30, 2024 , changes in goodwill reflect the effects of foreign currency exchange rates of $ 1.3 million and adjustments of $ 0.4 million from the completion of our Goldwell of NY, Inc. acquisition fair value assessment. Additionally, the changes to other intangibles included effects of foreign currency exchange rates of $ 0.6 million.

8. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

June 30,
2024

September 30,
2023

Compensation and benefits

$

56,892

$

69,915

Deferred revenue

17,221

18,259

Interest payable

15,926

13,447

Rental obligations

11,073

11,266

Insurance reserves

7,604

6,656

Property and other taxes

1,708

2,617

Operating accruals and other

50,767

41,206

Total accrued liabilities

$

161,191

$

163,366

9. Short-term and Long-term Debt

At June 30, 2024 , our ABL facility had $ 45.0 million in outstanding borrowings and $ 437.6 million available for borrowing, including the Canadian sub-facility, subject to borrowing base limitation, as reduced by outstanding letters of credit.

On February 12, 2024, we announced a registered public offering of 6.75 % senior notes due 2032 (“2032 Senior Notes”). This offering was made pursuant to a shelf registration statement on Form S-3 filed with the SEC on May 10, 2021. On February 27, 2024, we closed on the 2032 Senior Notes and received $ 594.0 million in cash proceeds, net of underwriter fees. The proceeds were used to repay the outstanding $ 680.0 million principal balance on the 5.625 % senior notes due 2025 (the “2025 Senior Notes”). The 2032 Senior Notes were issued at par and bear interest at a fixed interest rate of 6.75 %. Interest is paid semi-annually during our second and fourth fiscal quarters. The 2032 Senior Notes are guaranteed on a senior secured basis by the guarantors who have guaranteed obligations under our senior secured credit facilities and our existing notes. In connection with the issuance, we incurred approximately $ 8.5 million in debt issuance costs that are being amortized using the effective interest rate method through the life of the notes.

Additionally, on February 12, 2024, we issued a notice to redeem the entire $ 680.0 million aggregate outstanding principal amount of the 2025 Senior Notes that remained outstanding on March 13, 2024, at a redemption price equal to 100.00 % of the principal amount of the 2025 Senior Notes, plus accrued and unpaid interest to, but not including, the redemption date. On March 13, 2024, we redeemed the 2025 Senior Notes with the proceeds of our newly-issued 2032 Senior Notes, cash on hand prior to the issuance of the new 2032 Senior Notes, and ABL borrowings. In connection with this redemption, we recognized a $ 2.0 million loss on the extinguishment of debt within interest expense related to unamortized debt issuance costs.

12


On June 14, 2024, we entered into a second refinancing amendment, where we negotiated a 50 basis point reduction in the fixed interest spread on our term loan B facility (“TLB 2030”). The TLB 2030 now bears interest at a floating rate equal to, at our option, either the Adjusted Term SOFR Rate plus 1.75 % or an adjusted base rate plus 0.75 %. No other terms of the agreement were amended. In connection with the repricing, we evaluated the fair value of the debt, before and after the amendment, for each syndicate loan and accounted for the transaction as both a partial extinguishment and modification. As a result, we recognized a loss on extinguishment of $ 1.7 million within interest expense. In connection with the repricing, we incurred additional immaterial costs, of which the majority were recorded to interest expense. Furthermore, the extinguishment of debt and subsequent exchange of new debt with existing creditors resulted in non-cash financing activities of $ 20.5 million.

10. Derivative Instruments and Hedging Activities

During the nine months ended June 30, 2024 , we did no t purchase or hold any derivative instruments for trading or speculative purposes. See Note 4, Fair Value Measurements , for the classification and fair value of our derivative instruments.

Designated Cash Flow Hedges

Foreign Currency Forwards

We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on forecasted inventory purchases in U.S. dollars by our foreign subsidiaries. At June 30, 2024, we held forwards, which expire ratably through September 30, 2024, with a notional amount, based upon exchange rates at June 30, 2024 , as follows (in thousands):

Notional Currency

Notional Amount

Mexican Peso

$

5,041

Euro

2,904

Canadian Dollar

2,823

Total

$

10,768

The changes in fair value related to these foreign currency forwards are recorded quarterly into AOCL. As the forwards are exercised, the realized value is recognized into cost of goods sold (“COGS”), based on inventory turns, in our condensed consolidated statements of earnings. For the three months ended June 30, 2024 and 2023 , we recognized a loss of $ 0.4 million and a loss of $ 0.7 million, respectively. For the nine months ended June 30, 2024 and 2023 , we recognized a loss of $ 2.5 million and a loss of $ 0.6 million, respectively. Based on June 30, 2024 , valuations and exchange rates, we expect to reclassify losses of approximately $ 0.7 million out of AOCL and into COGS over the next 12 months.

Interest Rate Swap

In April 2023, we entered into a three-year interest rate swap with an initial notional amount of $ 200 million (the “interest rate swap”) to mitigate the exposure to higher interest rates in connection with our Term Loan B due in 2030. The interest rate swap involves fixed monthly payments at the contract rate of 3.705 %, and. in return, we will receive a floating interest payment based on the 1-month Adjusted Term SOFR Rate. The interest rate swap will mature in April 2026 and is designated as a cash flow hedge. Changes in the fair value of the interest rate swap are recorded quarterly, net of income tax, and included in AOCL.

For the three and nine months ended June 30, 2024 , we recognized income of $ 0.8 million and $ 2.5 million, respectively, into interest expense on our condensed consolidated statements of earnings related to the interest rate swap. For the three and nine months ended June 30, 2023 , we recognized income of $ 0.5 million into interest expense on our condensed consolidated statements of earnings. At June 30, 2024 , we expect to reclassify gains of approximately $ 2.4 million out of AOCL and into interest expense over the next 12 months.

Interest Rate Caps

In July 2017, we purchased two interest rate caps with an initial aggregate notional amount of $ 550 million (the “interest rate caps”) to mitigate the exposure to higher interest rates in connection with our prior term loan due 2024. The interest rate caps were comprised of individual caplets and were designated as cash flow hedges. Accordingly, the changes in fair value of the interest rate caps were recorded quarterly, net of income tax, and included in AOCL. During fiscal year 2023, we early settled both interest rate caps due to the forecasted transactions, which were being hedged, no longer occurring as a result of the repayment of our prior term loan. The effects of our interest rate caps on our condensed consolidated statements of earnings were not material for the three months ended June 30, 2023. For the nine months ended June 30, 2023 , we recognized income of $ 2.8 million into interest expense on our condensed consolidated statements of earnings related to the caps.

13


Non-Designated Derivative Instruments

We also use foreign exchange contracts to mitigate our exposure to exchange rate changes in connection with certain intercompany balances not permanently invested. At June 30, 2024, we held forwards, which settle on various dates in the first month of the next two fiscal quarters, with a notional amount, based upon exchange rates at June 30, 2024 , as follows (in thousands):

Notional Currency

Notional Amount

British Pound

$

45,392

Euro

21,321

Mexican Peso

20,768

Canadian Dollar

16,879

Total

$

104,360

We record changes in fair value and realized gains or losses related to these foreign currency forwards into selling, general and administrative expenses. For the three months ended June 30, 2024 and 2023 , the effects of these foreign exchange contracts on our condensed consolidated financial statements were gains of $ 0.8 million and losses of $ 1.5 million, respectively. For the nine months ended June 30, 2024 and 2023 , the effects of these foreign exchange contracts on our condensed consolidated financial statements were losses of $ 0.8 million and losses of $ 2.6 million, respectively.

11. Segment Reporting

Segment data for the three and nine months ended June 30, 2024 and 2023, is as follows (in thousands):

Three Months Ended
June 30,

Nine Months Ended
June 30,

2024

2023

2024

2023

Net sales:

SBS

$

536,536

$

534,932

$

1,573,015

$

1,614,650

BSG

405,804

396,076

1,208,988

1,192,125

Total

$

942,340

$

931,008

$

2,782,003

$

2,806,775

Earnings before provision for income taxes:

Segment operating earnings:

SBS

$

86,938

$

88,683

$

241,387

$

279,991

BSG

46,753

48,696

134,395

135,603

Segment operating earnings

133,691

137,379

375,782

415,594

Unallocated expenses

61,538

46,857

174,954

149,396

Restructuring

383

397

361

18,077

Consolidated operating earnings

71,770

90,125

200,467

248,121

Interest expense

20,707

18,654

58,544

53,262

Earnings before provision for income taxes

$

51,063

$

71,471

$

141,923

$

194,859

Sales between segments, which are eliminated in consolidation, were not material during the three and nine months ended June 30, 2024 and 2023.

14


Disaggregation of net sales by segment

Periodically, we make minor adjustments to our product hierarchy, which impacts the roll-up of our merchandise categories. As a result, certain prior year amounts have been reclassified to conform to current year presentation. The following tables disaggregate our segment revenues by merchandise category.

Three Months Ended
June 30,

Nine Months Ended
June 30,

SBS

2024

2023

2024

2023

Hair color

40.6

%

40.5

%

39.7

%

39.6

%

Hair care

24.2

%

23.8

%

24.5

%

23.8

%

Styling tools and supplies

16.2

%

17.2

%

17.1

%

18.2

%

Nail

10.5

%

10.1

%

10.2

%

10.1

%

Skin and cosmetics

8.1

%

7.9

%

8.0

%

7.6

%

Other beauty items

0.4

%

0.5

%

0.5

%

0.7

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

Three Months Ended
June 30,

Nine Months Ended
June 30,

BSG

2024

2023

2024

2023

Hair care

41.7

%

40.8

%

42.1

%

42.2

%

Hair color

41.8

%

41.6

%

40.9

%

40.1

%

Styling tools and supplies

10.3

%

10.6

%

10.5

%

10.7

%

Skin and cosmetics

3.4

%

4.0

%

3.7

%

4.1

%

Nail

2.5

%

2.7

%

2.4

%

2.7

%

Other beauty items

0.3

%

0.3

%

0.4

%

0.2

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

The following tables disaggregate our segment revenue by sales channels:

Three Months Ended
June 30,

Nine Months Ended
June 30,

SBS

2024

2023

2024

2023

Company-operated stores

93.0

%

94.1

%

93.2

%

93.8

%

E-commerce

7.0

%

5.9

%

6.8

%

6.2

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

Three Months Ended
June 30,

Nine Months Ended
June 30,

BSG

2024

2023

2024

2023

Company-operated stores

68.5

%

67.6

%

68.3

%

67.2

%

E-commerce

13.4

%

13.0

%

13.7

%

13.4

%

Distributor sales consultants

10.7

%

11.6

%

10.6

%

11.9

%

Franchise stores

7.4

%

7.8

%

7.4

%

7.5

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

15


12. Restructuring

Restructuring expenses, included in COGS and Restructuring for the three and nine months ended June 30, 2024 and 2023, are as follows (in thousands):

Three Months Ended
June 30,

Nine Months Ended
June 30,

2024

2023

2024

2023

Included in COGS (a)

Distribution Center Consolidation and Store Optimization Plan

$

$

( 746

)

$

$

( 5,788

)

Included in Restructuring (b)

Distribution Center Consolidation and Store Optimization Plan

$

383

$

397

$

361

$

18,077

(a)
Amounts included in COGS relate to adjustments to our expected obsolescence reserve related to the Plan (as defined below).
(b)
For the three and nine months ended June 30, 2023, restructuring consisted of closing costs related to lease terminations and employee termination benefits. The nine months ended June 30, 2023 , also included $ 2.1 million in impairment charges.

Distribution Center Consolidation and Store Optimization Plan

In the fourth quarter of fiscal year 2022, our Board approved the Distribution Center Consolidation and Store Optimization Plan (the Plan ) authorizing the closure of 330 SBS stores and 35 BSG stores, and the closure of two BSG distribution centers in Clackamas, Oregon and Pottsville, Pennsylvania. Stores identified for early closure were part of a strategic evaluation, which included a market analysis of certain locations where we believed we would be able to recapture demand and improve profitability.

The Plan has been substantially completed, as the remaining two BSG stores were closed earlier this fiscal year. However, we may still incur future immaterial charges related to store closures, such as exit costs, lease negotiation penalties and adjustments to estimates. As of June 30, 2024 , there were no material outstanding liabilities for exit costs or involuntary employee termination benefits.

16


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This section discusses management’s view of the financial condition, results of operations and cash flows of Sally Beauty for the periods covered by this Quarterly Report. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, including the Risk Factors sections therein, and information contained elsewhere in this Quarterly Report, including the condensed consolidated interim financial statements and notes to those financial statements.

Financial Summary for the Three Months Ended June 30, 2024

Consolidated net sales for the three months ended June 30, 2024, increased $11.3 million, or 1.2%, to $942.3 million, compared to the three months ended June 30, 2023. Consolidated net sales included a net negative impact from changes in foreign currency exchange rates of $1.0 million;
Consolidated comparable sales increased 1.5% for the three months ended June 30, 2024;
Consolidated gross profit for the three months ended June 30, 2024, increased $6.2 million, or 1.3%, to $480.9 million, compared to the three months ended June 30, 2023. Consolidated gross margin remained unchanged at 51.0% for the three months ended June 30, 2024, compared to the three months ended June 30, 2023;
Consolidated operating earnings for the three months ended June 30, 2024, decreased $18.4 million, or 20.4%, to $71.8 million, compared to the three months ended June 30, 2023. Operating margin decreased 210 bps to 7.6% for the three months ended June 30, 2024, compared to the three months ended June 30, 2023;
For the three months ended June 30, 2024, our consolidated net earnings decreased $13.1 million, or 25.8%, to $37.7 million, compared to the three months ended June 30, 2023;
For the three months ended June 30, 2024, our diluted earnings per share was $0.36 compared to $0.46 for the three months ended June 30, 2023; and
Cash provided by operations was $47.9 million for the three months ended June 30, 2024, compared to $53.1 million for the three months ended June 30, 2023.

Comparable Sales

We believe that comparable sales is an appropriate performance indicator to measure our sales growth compared to the prior period. O ur comparable sales include sales from stores that have been operating for 14 months or longer as of the last day of a month and from e-commerce revenue. Additionally, comparable sales include sales to franchisees and full service sales. Our comparable sales excludes the effect of changes in foreign exchange rates and sales from stores relocated until 14 months after the relocation. Revenue from acquired stores are excluded from our comparable sales calculation until 14 months after the acquisition. Our calculation of comparable sales might not be the same as other retailers as the calculation varies across the retail industry.

17


Overview

Key Operating Metrics

The following table sets forth, for the periods indicated, information concerning key measures on which we rely to evaluate our operating performance (dollars in thousands):

Three Months Ended June 30,

Nine Months Ended June 30,

2024

2023

Increase (Decrease)

2024

2023

Increase (Decrease)

Net sales:

SBS

$

536,536

$

534,932

$

1,604

0.3

%

$

1,573,015

$

1,614,650

$

(41,635

)

(2.6

)%

BSG

405,804

396,076

9,728

2.5

%

1,208,988

1,192,125

16,863

1.4

%

Consolidated

$

942,340

$

931,008

$

11,332

1.2

%

$

2,782,003

$

2,806,775

$

(24,772

)

(0.9

)%

Gross profit:

SBS

$

321,051

$

314,474

$

6,577

2.1

%

$

935,189

$

955,066

$

(19,877

)

(2.1

)%

BSG

159,832

160,231

(399

)

(0.2

)%

475,942

476,552

(610

)

(0.1

)%

Consolidated

$

480,883

$

474,705

$

6,178

1.3

%

$

1,411,131

$

1,431,618

$

(20,487

)

(1.4

)%

Segment gross margin:

SBS

59.8

%

58.8

%

100

bps

59.5

%

59.2

%

30

bps

BSG

39.4

%

40.5

%

(110)

bps

39.4

%

40.0

%

(60)

bps

Consolidated

51.0

%

51.0

%

bps

50.7

%

51.0

%

(30)

bps

Net earnings:

Segment operating earnings:

SBS

$

86,938

$

88,683

$

(1,745

)

(2.0

)%

$

241,387

$

279,991

$

(38,604

)

(13.8

)%

BSG

46,753

48,696

(1,943

)

(4.0

)%

134,395

135,603

(1,208

)

(0.9

)%

Segment operating earnings

133,691

137,379

(3,688

)

(2.7

)%

375,782

415,594

(39,812

)

(9.6

)%

Unallocated expenses and restructuring (a)

61,921

47,254

14,667

31.0

%

175,315

167,473

7,842

4.7

%

Consolidated operating earnings

71,770

90,125

(18,355

)

(20.4

)%

200,467

248,121

(47,654

)

(19.2

)%

Interest expense

20,707

18,654

2,053

11.0

%

58,544

53,262

5,282

9.9

%

Earnings before provision for income taxes

51,063

71,471

(20,408

)

(28.6

)%

141,923

194,859

(52,936

)

(27.2

)%

Provision for income taxes

13,339

20,650

(7,311

)

(35.4

)%

36,565

52,840

(16,275

)

(30.8

)%

Net earnings

$

37,724

$

50,821

$

(13,097

)

(25.8

)%

$

105,358

$

142,019

$

(36,661

)

(25.8

)%

.

Comparable sales growth (decline):

SBS

0.7

%

3.0

%

(230)

bps

(1.7

)%

5.0

%

(670)

bps

BSG

2.6

%

(2.4

)%

500

bps

1.8

%

(0.9

)%

270

bps

Consolidated

1.5

%

0.6

%

90

bps

(0.2

)%

2.4

%

(260)

bps

Number of stores at end-of-period (including franchises):

SBS

3,128

3,141

(13

)

(0.4

)%

BSG

1,332

1,336

(4

)

(0.3

)%

Consolidated

4,460

4,477

(17

)

(0.4

)%

(a)
Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. Additionally, unallocated expenses include costs associated with our Fuel for Growth initiative. Restructuring costs included in this line are related to our Distribution Center Consolidation and Store Optimization Plan. See Note 12 for more information.

18


Results of Operations

The Three Months Ended June 30, 2024, compared to the Three Months Ended June 30, 2023

Net Sales

SBS . The increase in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales

$

3,643

Sales outside comparable sales (a)

(1,706

)

Foreign currency exchange

(333

)

Total

$

1,604

(a)
Includes closed stores, net of stores opened for less than 14 months.

SBS’s net sales increase was primarily driven by an increase in comparable sales, partially offset by the impact of closed stores. SBS’s increase in comparable sales was driven by improved new and reactivated customer trends as key strategic initiatives continue to mature.

BSG . The increase in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

$

10,063

Sales outside comparable sales (a)

302

Foreign currency exchange

(637

)

Total

$

9,728

(a)
Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months and sales from acquired stores.

BSG’s net sales increase was primarily driven by an increase in comparable sales, reflecting expanded distribution, new brand innovation and improving salon demand trends, partially offset by unfavorable impacts of foreign currency exchange rates.

Gross Profit

SBS . SBS’s gross profit increased for the three months ended June 30, 2024, as a result of an increase in net sales and a higher gross margin on units sold. SBS’s gross margin improvement was driven primarily by lower distribution and freight costs from supply chain efficiencies and higher product margins, partially offset by unfavorable fixed cost absorption.

BSG . BSG’s gross profit was flat for the three months ended June 30, 2024, as a result of a lower gross margin on units sold, offset by an increase in net sales. BSG’s gross margin decline was driven by an unfavorable fixed cost absorption and lower product margins, primarily from higher take rate on promotions and brand mix, partially offset by lower distribution and freight costs from supply chain efficiencies.

Selling, General and Administrative Expenses

SBS . SBS’s selling, general and administrative expenses increased $8.3 million, or 3.7%, for the three months ended June 30, 2024. As a percentage of SBS net sales, selling, general and administrative expense for the three months ended June 30, 2024, was 43.6%, compared to 42.2% for the three months ended June 30, 2023. The increase as a percentage of sales was primarily due to higher labor and other compensation-related expenses, depreciation expense, and advertising expense.

BSG . BSG’s selling, general and administrative expenses increased $1.5 million, or 1.4%, for the three months ended June 30, 2024. As a percentage of BSG net sales, selling, general and administrative expense for the three months ended June 30, 2024, was 27.9% compared to 28.2% for the three months ended June 30, 2023. The decrease as a percentage of sales was primarily due to higher net sales, partially offset by higher depreciation expense.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $14.7 million, or 31.3%, for the three months ended June 30, 2024, primarily due to expenses in connection with our Fuel for Growth initiative and higher labor and other compensation-related expenses.

Interest Expense

The increase in interest expense is primarily due to the repricing of our Term Loan B which resulted in the recognition of $1.7 million in losses on debt extinguishment. See Note 9, Short-term and Long-term Debt , in Item 1 of this quarterly report for more information on our debt.

19


Provision for Income Taxes

The effective tax rates were 26.1% and 28.9% for the three months ended June 30, 2024 and 2023, respectively. The decrease in the effective tax rate was primarily due to additional taxes and interest paid in the prior year quarter for the one-time transition tax on unrepatriated foreign earnings (“Repatriation Tax”) related to the fiscal year ended September 30, 2018.

The Nine Months Ended June 30, 2024, compared to the Nine Months Ended June 30, 2023

Net Sales

SBS . The decrease in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales

$

(27,426

)

Sales outside comparable sales (a)

(27,167

)

Foreign currency exchange

12,958

Total

$

(41,635

)

(a)
Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months.

SBS’s net sales decrease was primarily driven by fewer comparable sales and the impact of store closures, which includes $23.8 million resulting from the Plan, of which, a significant portion was recaptured in other locations that are included within comparable sales. These decreases were partially offset by a favorable impact from foreign currency exchange rates. SBS’s comparable sales decline was a result of fewer transactions, partially offset by growth in our average unit retail, driven by inflationary impacts and pricing leverage.

BSG . The increase in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

$

20,630

Sales outside comparable sales (a)

(3,130

)

Foreign currency exchange

(637

)

Total

$

16,863

(a)
Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months and sales from acquired stores.

BSG’s net sales increase was primarily driven by an increase in comparable sales, reflecting expanded distribution, new brand innovation and improving salon demand trends, partially offset by the impact of store closures and the unfavorable impact from foreign currency exchange rates.

Gross Profit

SBS . SBS’s gross profit decreased for the nine months ended June 30, 2024, as a result of a decrease in net sales, partially offset by higher gross margin on units sold. SBS’s gross margin improvement was primarily due to lower distribution and freight costs from supply chain efficiencies and higher product margins, partially offset by unfavorable fixed cost absorption.

BSG . BSG’s gross profit was flat for the nine months ended June 30, 2024, as a result of a lower gross margin on units sold, offset by an increase in net sales. BSG’s gross margin decline was driven primarily by unfavorable fixed cost absorption, shrink expense, and adjustments to our expected obsolescence reserve related to the Plan in the prior year, partially offset by lower distribution and freight costs from supply chain efficiencies.

Selling, General and Administrative Expenses

SBS . SBS’s selling, general and administrative expenses increased $18.7 million, or 2.8%, for the nine months ended June 30, 2024, and included an unfavorable impact from foreign exchange rates of $4.8 million and cost savings from store closures in connection with the Plan. As a percentage of SBS net sales, selling, general and administrative expense for the nine months ended June 30, 2024, was 44.1% compared to 41.8% for the nine months ended June 30, 2023. The increase as a percentage of sales was primarily due to higher labor and other compensation-related expenses, rent expense, depreciation expense, and advertising expense.

BSG . BSG’s selling, general and administrative expenses decreased $0.6 million, or 0.2%, for the nine months ended June 30, 2024. As a percentage of BSG net sales, selling, general and administrative expense for the nine months ended June 30, 2024, was 28.3% compared to 28.6% for the nine months ended June 30, 2023. The decrease as a percentage of sales was driven primarily by higher net sales and lower delivery expense.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $25.6 million, or 17.1%, for the nine months ended June 30, 2024, primarily due to expenses in connection with our Fuel for Growth initiative in the current year.

20


Restructuring

The decrease in restructuring was primarily due to the lapping of expenses incurred in connection with the Plan in the prior year for $18.1 million. See Note 12, Restructuring , in Item 1 of this quarterly report for more information on the Plan.

Interest Expense

The increase in interest expense is primarily due to the impacts of higher interest rates and debt extinguishment, partially offset by lower average outstanding borrowings on our ABL facility during the current year. See Note 9, Short-term and Long-term Debt , and Note 10, Derivative Instruments and Hedging Activities , in Item 1 of this quarterly report for more information on our debt and interest rate swap that has helped mitigate some of the additional interest costs resulting from higher interest rates.

Provision for Income Taxes

The effective tax rates were 25.8% and 27.1% for the nine months ended June 30, 2024 and 2023, respectively. The decrease in the effective tax rate was primarily due to Repatriation Tax related to the fiscal year ended September 30, 2018.

Liquidity and Capital Resources

Overview

Our principal sources of liquidity are cash from operations, cash and cash equivalents and borrowings under our ABL facility. A substantial portion of our liquidity needs arise from funding the costs of our operations, working capital, capital expenditures, debt interest and principal payments. Additionally, under our share repurchase program (see below for more details) we will from time to time repurchase shares of our common stock on the open market to return value to our shareholders. At June 30, 2024, we had $535.0 million in our liquidity pool, which includes $437.6 million available for borrowing under our ABL facility and cash and cash equivalents of $97.4 million.

Our working capital (current assets less current liabilities) increased $18.9 million, to $667.6 million at June 30, 2024, compared to $648.7 million at September 30, 2023. The increase was primarily driven by an increase in inventory, as a result of expanded distribution rights in BSG and vendor price increases, and the timing of account payables and lease renewals. These impacts were partially offset by higher borrowings under our ABL facility and a decrease in cash and cash equivalents.

We anticipate that existing cash balances (excluding certain amounts permanently invested in connection with foreign operations), cash expected to be generated by operations, and funds available under our ABL facility will be sufficient to fund our working capital and capital expenditure requirements over the next twelve months.

Cash Flows

Nine Months Ended June 30,

(in thousands)

2024

2023

Net cash provided by operating activities

$

135,855

$

132,771

Net cash used by investing activities

(64,026

)

(63,796

)

Net cash used by financing activities

(97,835

)

(68,259

)

Net Cash Provided by Operating Activities

The increase in cash provided by operating activities was primarily driven by the timing of interest and tax payments and the impact of lease contract termination and severance payments in connection with the Plan in the prior year, partially offset by fewer cash receipts from customers, higher inventory purchases and the timing of vendor and manufacturing allowances.

Net Cash Used by Investing Activities

Cash used by investing activities was relatively unchanged. Our capital expenditures related primarily to store improvements and system upgrades.

Net Cash Used by Financing Activities

The increase in cash used by financing activities was primarily due to shares repurchased in the current year under our share repurchase program and an increase in debt issuance costs, partially offset by fewer reductions in our debt outstanding in the current year compared to the prior year.

Debt and Guarantor Financial Information

During the current fiscal year, we issued $600.0 million in 2032 Senior Notes and used the proceeds, together with cash on hand and borrowings under our ABL facility, to repay in full our 2025 Senior Notes. See Note 9, Short-term and Long-term Debt , in Item 1 of this quarterly report for more information on our debt.

21


At June 30, 2024, we had $1.0 billion in outstanding debt principal, excluding finance lease obligations, unamortized debt issuance costs and debt discounts, in the aggregate, of $12.1 million. Our debt consists of $600.0 million in 2032 Senior Notes outstanding, $395.0 million remaining on our term loan and $45.0 million in outstanding borrowings under our ABL facility.

We utilize our ABL facility for the issuance of letters of credit, certain working capital and liquidity needs, and to manage normal fluctuations in our operational cash flow. In that regard, we may from time to time draw funds under the ABL facility for general corporate purposes including funding of capital expenditures, acquisitions, paying down other debt and share repurchases. Amounts drawn on our ABL facility are generally paid down with cash provided by our operating activities. During the nine months ended June 30, 2024, the weighted average interest rate on our borrowings under the ABL facility was 7.3%.

We are currently in compliance with the agreements and instruments governing our debt, including our financial covenants.

Guarantor Financial Information

Our 2032 Senior Notes were issued by our wholly-owned subsidiaries, Sally Holdings LLC and Sally Capital Inc. (together, the “Issuers”). The notes are unsecured debt instruments guaranteed by us and certain of our wholly-owned domestic subsidiaries (together, the “Guarantors”) and have certain restrictions on the ability of our subsidiaries to make certain restrictive payments to Sally Beauty. The guarantees are joint and several, and full and unconditional. Certain other subsidiaries, including our foreign subsidiaries, do not serve as guarantors.

The following summarized consolidating financial information represents financial information for the Issuers and the Guarantors on a combined basis. All transactions and intercompany balances between these combined entities have been eliminated.

The following table presents the summarized balance sheets information for the Issuers and the Guarantors as of June 30, 2024, and September 30, 2023:

(in thousands)

June 30, 2024

September 30, 2023

Cash and cash equivalents

$

36,072

$

66,148

Inventory

$

776,321

$

735,853

Intercompany receivable

$

$

1,658

Current assets

$

903,773

$

890,462

Total assets

$

2,056,612

$

2,076,413

Current liabilities

$

486,539

$

468,202

Intercompany payable

$

5,181

$

Total liabilities

$

1,942,100

$

2,011,075

The following table presents the summarized statement of earnings information for the Issuers and the Guarantors for the nine months ended June 30, 2024 (in thousands):

Net sales

$

2,238,653

Gross profit

$

1,150,791

Earnings before provision for income taxes

$

113,978

Net Earnings

$

85,717

Share Repurchase Programs

Under our current share repurchase program, we may from time to time repurchase our common stock on the open market. During the three and nine months ended June 30, 2024, we repurchased 0.9 million and 4.3 million shares of our common stock for $10.0 million and $50.0 million, respectively, under our share repurchase program, excluding the impact of excise taxes. During the three and nine months ended June 30, 2023, no shares were repurchased in connection with our share repurchase program. See Note 5, Stockholders’ Equity , for more information about our share repurchase program.

Contractual Obligations

Other than our debt, as discussed above, there have been no material changes outside the ordinary course of our business to our contractual obligations since September 30, 2023.

Off-Balance Sheet Financing Arrangements

At June 30, 2024, and September 30, 2023, we had no off-balance sheet financing arrangements other than outstanding letters of credit related to inventory purchases and self-insurance programs.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates or assumptions since September 30, 2023.

22


Recent Accounting Pronouncements

See Note 2 of the Notes to Condensed Consolidated Financial Statements in Item 1 – “Financial Statements” in Part I – Financial Information.

23


Item 3. Quantitative and Qualitat ive Disclosures About Market Risk

As a multinational corporation, we are subject to certain market risks including foreign currency fluctuations, interest rates and government actions. There have been no material changes to our market risks from September 30, 2023. See our disclosures about market risks contained in Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

Item 4. Controls and Procedures

Controls Evaluation and Related CEO and CFO Certifications. Our management, with the participation of our principal executive officer (“CEO”) and principal financial officer (“CFO”), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2024. The controls evaluation was conducted by our Disclosure Committee, comprised of senior representatives from our finance, accounting, internal audit, and legal departments under the supervision of our CEO and CFO.

Certifications of our CEO and our CFO, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Quarterly Report. This “Controls and Procedures” section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Limitations on the Effectiveness of Controls. We do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A system of controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the system are met. Because of the limitations in all such systems, no evaluation can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Furthermore, the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how unlikely. Because of these inherent limitations in a cost-effective system of controls and procedures, misstatements or omissions due to error or fraud may occur and not be detected.

Scope of the Controls Evaluation. The evaluation of our disclosure controls and procedures included a review of their objectives and design, our implementation of the controls and procedures and the effect of the controls and procedures on the information generated for use in this Quarterly Report. In the course of the evaluation, we sought to identify whether we had any data errors, control problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, was being undertaken if needed. This type of evaluation is performed on a quarterly basis so that conclusions concerning the effectiveness of our disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated by our internal audit department, by our legal department and by personnel in our finance organization. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures on an ongoing basis and to maintain them as dynamic systems that change as conditions warrant.

Conclusions regarding Disclosure Controls. Based on the required evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that, as of June 30, 2024, we maintain disclosure controls and procedures that are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting. During our most recent fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

24


PART II — OTHE R INFORMATION

We are involved, from time to time, in various claims and lawsuits incidental to the conduct of our business in the ordinary course. We carry insurance coverage in such amounts in excess of our self-insured retention as we believe to be reasonable under the circumstances and that may or may not cover any or all of our liabilities in respect of these matters. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, cash flows or results of operations.

We are subject to a number of U.S., federal, state and local laws and regulations, as well as the laws and regulations applicable in each foreign country or jurisdiction in which we do business. These laws and regulations govern, among other things, the composition, packaging, labeling and safety of the products we sell, the methods we use to sell these products and the methods we use to import these products. We believe that we are in material compliance with such laws and regulations, although no assurance can be provided that this will remain true going forward.

Item 1A. Ri sk Factors

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors contained in Item 1A. “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, which could materially affect our business, financial condition or future results. There have been no material changes from the risk factors disclosed in such Annual Report. The risks described in such Annual Report and herein are not the only risks facing our company.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

Information regarding shares of common stock we repurchased during the third quarter of fiscal year 2024, excluding the impact of excise taxes, is as follows:

Fiscal Period

Total Number of Shares Purchased (1)

Average Price Paid per Share (2)

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)

Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs

Apr 1 - Apr 30, 2024

$

$

540,792,435

May 1 - May 31, 2024

581,972

11.16

581,972

534,295,204

Jun 1 - Jun 30, 2024

294,003

11.91

294,003

530,792,437

Total this quarter

875,975

$

11.42

875,975

$

530,792,437

(1)
In July 2021, we announced that our Board of Directors had approved a term extension to our share repurchase program authorizing us to repurchase up to $1.0 billion of our common stock over an approximate four-year period expiring on September 30, 2025.
(2)
The calculation of the average price paid per share includes the impact of commissions paid in connection with the shares repurchased.

Item 5. Other Information

During the quarter ended June 30, 2024 , no director or officer of the Company adopted , modified , or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408(a) of Regulation S-K.

25


Item 6. E xhibits

Exhibit No.

Description

3.1

Third Restated Certificate of Incorporation of Sally Beauty Holdings, Inc., dated January 30, 2014, which is incorporated herein by reference from Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on January 30, 2014

3.2

Amended and Restated Bylaws of Sally Beauty Holdings, Inc., dated April 26, 2017, which is incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on April 28, 2017

4.1

Fifth Supplemental Indenture, dated as of February 27, 2024, by and among Sally Holdings LLC, Sally Capital Inc., the guarantors listed therein and Computershare Trust Company, N.A, which is incorporated herein by reference from Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on February 27, 2024

4.2

Second Refinancing Amendment to Credit Agreement, dated as of June 14, 2024, by and among Sally Holdings LLC, Sally Capital Inc., Sally Beauty Holdings, Inc., Sally Investment Holdings LLC, Bank of America, N.A., as Administrative Agent and Collateral Agent, and the lenders and other parties thereto.*

22

List of Subsidiary Guarantors*

31.1

Rule 13a-14(a)/15d-14(a) Certification of Denise Paulonis*

31.2

Rule 13a-14(a)/15d-14(a) Certification of Marlo M. Cormier*

32.1

Section 1350 Certification of Denise Paulonis*

32.2

Section 1350 Certification of Marlo M. Cormier*

101

The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Earnings; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements.

104

The cover page from our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, formatted in iXBRL (contained in Exhibit 101).

* Included herewith

26


SIGNA TURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SALLY BEAUTY HOLDINGS, INC.

(Registrant)

Date: August 8, 2024

By:

/s/ Marlo M. Cormier

Marlo M. Cormier

Senior Vice President, Chief Financial Officer

For the Registrant and as its Principal Financial Officer

27


TABLE OF CONTENTS
Part I FinanciItem 1. Financial StatementsItem 1. FinanciItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 2. Management S Discussion and Analysis OfItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 3. Quantitative and QualitatItem 4. Controls and ProceduresItem 4. ControlsPart II Other InformationPart II OtheItem 1. Legal ProceedingsItem 1. LegalItem 1A. Risk FactorsItem 1A. RiItem 2. Unregistered Sales Of Equity Securities, Use Of Proceeds, and Issuer Purchases Of Equity SecuritiesItem 5. Other InformationItem 6. Exhibits

Exhibits

3.1 Third Restated Certificate of Incorporation of Sally Beauty Holdings, Inc., dated January 30, 2014, which is incorporated herein by reference from Exhibit 3.3 to the Companys Current Report on Form 8-K filed on January 30, 2014 3.2 Amended and Restated Bylaws of Sally Beauty Holdings, Inc., dated April 26, 2017, which is incorporated herein by reference from Exhibit 3.1 to the Companys Current Report on Form 8-K filed on April 28, 2017 4.1 Fifth Supplemental Indenture, dated as of February 27, 2024, by and among Sally Holdings LLC, Sally Capital Inc., the guarantors listed therein and Computershare Trust Company, N.A, which is incorporated herein by reference from Exhibit 4.2 to the Companys Current Report on Form 8-K filed on February 27, 2024 4.2 Second Refinancing Amendment to Credit Agreement, dated as of June 14, 2024, by and among Sally Holdings LLC, Sally Capital Inc., Sally Beauty Holdings, Inc., Sally Investment Holdings LLC, Bank of America, N.A., as Administrative Agent and Collateral Agent, and the lenders and other parties thereto.* 22 List of Subsidiary Guarantors* 31.1 Rule 13a-14(a)/15d-14(a) Certification of Denise Paulonis* 31.2 Rule 13a-14(a)/15d-14(a) Certification of Marlo M. Cormier* 32.1 Section 1350 Certification of Denise Paulonis* 32.2 Section 1350 Certification of Marlo M. Cormier*